Charles Russell Speechlys advise Apposite Capital on investment into OrthoD Group
Charles Russell Speechlys have advised new client Apposite Capital, the private equity firm with an exclusive focus on healthcare, on the acquisition of OrthoD Group from The Riverside Company.
OrthoD is a specialist manufacturer and distributor of medical products and implants for joint reconstruction, sport medicine, surgical products and infection control applications. Created in 1984, OrthoD is a UK based provider of specialist solutions for orthopaedic surgery. The company’s products range from bone cement management systems, wound drainage, fixation devices for knee and shoulder surgery and other specialist devices. The company has distribution channels in over 40 countries worldwide and employs over 100 people.
Apposite Capital sees significant potential in supporting management in further building OrthoD’s export channels and in further commercialising OrthoD’s sport medicine products.
Rory Pope, Partner, Apposite Capital who is also joining the board of OrthoD, said: “Medical devices companies are a key focus to Apposite and a sector where we have had excellent outcomes. We are delighted to support this MBO; OrthoD is a solid business which has built a strong reputation with its customers and we look forward supporting Daniel and the rest of the team to accelerate their growth ambitions for the business. A great job yet again from Malcolm, Richard and the whole Charles Russell Speechlys team, thank you for the great effort!”
Malcolm MacDougall, Corporate Partner, commented: “ We were delighted to work with Rory and the Apposite Capital team on our first transaction for them. OrthoD is an exciting and innovative business in the Healthcare space, tying in with what is one of our core focus areas. We look forward to working closely with the team in the future”.
The Charles Russell Speechlys core team included Malcolm MacDougall. Richard Coleman, Rajiv Kakkad, Hannah Dawson and Alice Mason.
Our thinking
Charlotte Healy
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Pei Li Kew
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Mark Howard
Charles Russell Speechlys advises Acora on its acquisition of Secrutiny
Charles Russell Speechlys advises Acora on its acquisition of Secrutiny
Fiona Edmond
A Material Cost to the Progress of Life Sciences Projects?
Nick White
Charles Russell Speechlys advises Symphony Holdings Limited on the sale of its PONY trade mark portfolio for USD $28 million
Charles Russell Speechlys advises Symphony Holdings Limited on the sale of its PONY trade mark portfolio for USD $28 million.
Simon Ridpath
Simon Ridpath featured in the Lawyer’s Hot 100 list
Simon Ridpath features in The Lawyer’s Hot 100 list
Mark Howard
Charles Russell Speechlys advises Europa Oil & Gas (Holdings) plc on its £7m equity fundraising
Europa Oil and Gas is a renewable energy, oil and gas development and production company.
Simon Green
International Bar Association quote Simon Green on the future of the legal sector in Hong Kong
International Bar Association quote Simon Green on the future of Hong Kong's legal sector
Patrick Chan
Corporate Treasurer publishes Patrick Chan's comments regarding the No Consent Regime
Corporate Treasurer publishes Patrick Chan's comments on the No Consent Regime
Jamie Cartwright
Jamie Cartwright comments on the potential impact of the plastic packaging tax
Jamie Cartwright comments on the potential impact of the plastic packaging tax
Louise Ward
The only way is UP for London Life Sciences
Rebecca Burford
Charles Russell Speechlys partners with the Crafty Counsel community
Crafty Counsel brings together in-house legal professionals to share their experiences.
Jonathan Morley
International Business Reports reported on the firm’s involvement advising Battery Ventures on the sale of Forterro to Partners Group for €1 billion
The firm has advised global, technology-focused investment firm Battery Ventures on the sale of Forterro to Partners Group for €1 billion.
David Hicks
David Hicks quoted by FT Adviser on why Succession sold up to Aviva
David Hicks explains that private equity backers have a time horizon for their investments.
Sarah Wigington
How will the new Economic Crime Levy impact residential development joint ventures?
The Economic Crime (Transparency and Enforcement) Bill is being created through Parliament this month.
Jonathan Morley
Charles Russell Speechlys is advising Battery Ventures on the sale of Forterro to Partners Group for €1 billion.
Battery Ventures is a the global, technology-focused investment firm.
Louise Ward
Louise Ward quoted by Estates Gazette on the fading support for the Ox-Cam Arc
The government is reported to be rowing back on driving investment to the region, which has been a hotbed of life sciences expertise.
Oliver Park
Oliver Park writes for P3 Pharmacy on the impact of the Building Safety Bill on pharmacy owners
A key requirement under the Order is the need for a fire risk assessment, which must be regularly reviewed.
David Coates
Charles Russell Speechlys advises on the acquisition of the Douglas & Gordon property sales business
Foxtons is a London listed property sales business.
Adrian Mayer
Charles Russell Speechlys advises AgDevCo on $70m of DFI Funding
AgDevCo is a specialist impact investor in African agribusinesses.